It Took Me 26 Years of Cancer Research to Learn What I’ll Teach You in 20 mins
In this 20‑minute presentation Dr. Dino Prato, founder of Invita Medical Centers, distills 26 years of treating thousands of cancer patients into practical guidance for newly diagnosed patients, families, and caregivers. He argues that a cancer diagnosis is merely a label and not a treatment plan, emphasizing the need for deep, N‑of‑1 molecular mapping (DNA, RNA, spatial, immune profiling) before committing to any therapy. He warns against the common mistake of rushing into standard protocols without sufficient data, and stresses the importance of obtaining a second opinion early, asking specific questions about testing, target identification, adaptive monitoring, and contingency plans. Prato critiques the blind spots of standard oncology and integrative care, which rely on population‑averaged guidelines and limited marker panels, and advocates for a multimodal, precision‑focused approach that integrates targeted on‑/off‑label drugs, immune activation, tumor microenvironment modulation, and supportive metabolic and nutritional strategies. He also highlights non‑clinical factors: caregiver well‑being, positive mindset, and early financial planning as essential components of successful cancer care. The core message is to pursue deep precision targeting from the outset rather than waiting until options run out.
Chapters
26 years, thousands of cancer patients, a clinic that grew from a one rented office into a facility that has more than 350 staff members, almost 400 today. Patients coming from over 50 countries and a peer-reviewed paper that shows powerful outcomes in late-stage cancer care. I'm gonna compress 26 years of treating cancer with our team and all our technology into 20 minutes. And the lessons I keep coming back to over and over again, the things our entire team wish everyone knew that was newly diagnosed with cancer. This is what we see when patients walk into our clinic. The mistakes that the standard system makes over and over again, and what we have done to help treat our own family members that were diagnosed with cancer in our center. I'm gonna walk you through all of this. I'm Dr. Dino Prato, founder of Invita Medical Centers. For the last 25 years, my team and I have treated thousands of cancer patients, many who were told there was nothing else that can be done from the top cancer hospitals here in the United States. And patients that have come from around the world. And I'm gonna walk you through these important pieces. But before we do anything, make sure you're always working with a doctor before you change any of your medical care. The first thing I want you to know is this: a diagnosis is not a strategy. And that may be the most important lesson in this entire podcast because most patients hear the word cancer, hear the stage, hear the name, and assume the plan is now obvious. Breast cancer, there must be a breast cancer plan. Colon cancer, there must be a colon cancer plan. Pancreatic cancer, there must be a pancreatic cancer plan. But after 26 years, I can tell you that's not how real cancer behaves. The diagnosis gives you a label. It does not give you the biology. It does not tell you the molecular drivers. It does not tell you the immune system barriers and the evasion of the immune system. It doesn't tell you whether the tumor's hot or cold or even active for immunity. It doesn't tell you what it will actually respond to. It doesn't tell you what resistance is there, and it definitely doesn't tell you why one patient with the same cancer does well while another patient with the same exact cancer doesn't, because they're not giving you sufficient data. That's why I've said it for years that cancer is not a disease of tissue. It's a disease of biology, of signaling, of immune escape. It's a disease of terrain. It's a disease that needs deep molecular mapping. And if you build your entire treatment plan off the name alone, the biopsy, the tumor markers, the imaging, the National Comprehensive Cancer Network guidelines, you may be treating a category instead of treating the actual disease that the patient has. So that's the first lesson. That's a really important lesson. Do not confuse the name of the disease with the map of the disease that can lead to the right treatment. The second lesson, the biggest mistake patients make in the first 2 weeks is moving too fast with too little information. This happens constantly. A patient gets a diagnosis, they're terrified, they get rushed into treatment, the family's panicked, everyone wants action. Let's take it out, let's move. And I understand that. That's normal. But in cancer, fast is not always smart. Sometimes fast is how you lock yourself into the wrong path before you actually understand the biology of the tumor. Now, I'm not saying delaying care and being reckless. No, not that at all. I'm saying get more information, make sure that the first steps are the right steps. Because what I see and what our team has seen over and over again with patients is they rush into the standard pathways. They even rush into integrative care and they're sold into these programs. They don't understand really what the right targets are. They rush into care before they've asked the right and most important questions. What are the tests that are you running? Are you running deep Multiomics, RNA, DNA, spatial biology, immune profiling. How are you building the treatment plan? On, off-label, integrative? Is it custom built for me? What has not been done for you yet? That's a question you wanna know because there'll be a lot of things that are missing. Do we have enough tissue? Do we have enough information? Have we done enough meaningful, deep molecular analysis? Do we understand the immune system landscape and the evasion of the immune system? Do we know what's caused the cancer? What's driving the tumor? Do we know that? Or are we guessing based on statistics and standards and one-size-fits-all guidelines or whatever's being given in the office. It helps you confirm a diagnosis of cancer, but it's not giving you all that information you think it is. That's not the same thing as telling you what are the real drivers of the disease with deep molecular profiling. So one of the first lessons that I would teach anybody who has cancer is don't let urgency steal your intelligence. Don't let fear drive you. Yes, urgency matters, but intelligence first. Dr. Dino Prato Prato. Because if you have wisdom and you have the right steps, you're gonna get better care. And here's the third thing patients get wrong all the time. They seek a second opinion too late. This is one of the most painful patterns to watch over the years. Patients first try standard of care, the first line failed, the second line failed, they're feeling weaker. Then they look for precision oncology. Then the cancer's more aggressive. Then the options are narrower. They're still there. There's many times great options. They can be found, but they're not as wide as if you catch it earlier. Then Everyone says, now let's get a second opinion. That's backwards thinking. The second opinion should happen early, right at the beginning, or as soon as you find out about the cancer so you can see all your options and have data. I would rather be treated with 1,000 markers. Everybody would. Then the basic 24 that's used in standard oncology. And if you're lucky, a few hundred with DNA. You want more information. This is gonna tell you a lot about the cancer. You wanna know What are the things that are driving the cancer? You wanna know more about your immune system. You don't just wanna jump into chemo, radiation, surgery, or even integrative care. You want to know what the drivers are so you can have the right plan. And you wanna know when to pivot. So you want adaptive monitoring so you can tell if the treatment's working or not very quickly. So you don't have to go through the whole course of treatment to find out if it's working or not, because it'll weaken you. You actually wanna know along care if you're responding or not and how the biology's responding. See, this is the power of getting a second opinion along care. When there's not been enough deep mapping and you've just followed the standard of care pathways and you did one round of chemo, second round of regimens, one after another. These are the questions you need to be asking yourself. If you're a child of the patient, a spouse, a parent, you want to get that deepest testing for your loved one sooner than later because it's smarter. You have more information right from the beginning. You know what your options are before you start moving into resistance. Cuz if you're on the wrong treatment, you'll actually push resistance and make treatment more difficult later on. So don't worry, this is not a betrayal to your doctor. Second opinion. Second opinions are important. They give you wisdom and direction. You would get a second opinion on anything else. If you're building architectural design or anything with your house, you're gonna want that, especially when you're fighting for your life. And then here's another mistake we see patients make very early on. They don't know what questions to ask their doctor. In these institutions that are large or whatever, and they're, they just like brought into these institutions and assume everything's gonna be okay. They know what they're doing. This is standard of care. It is not the best care. And the data sets you have are few that are guiding your care. It's not their fault. It's just what's billable. It's what the system does. It's how the hospitals work. Oftentimes these doctors are overwhelmed. They're seeing lots of patients. They don't have enough time, energy, deep testing to help. But you as a patient too are overwhelmed and you can be scared and rushed into treatments that you shouldn't be rushed into. You know, don't fall for the white coat syndrome. Ask all the right questions. Here are some of the questions you want to ask. Are you doing deep multi-omics testing? DNA, RNA, and immune spatial biology. Are you? And what are you going to do with that information? And what other additional tests are you running to look at the root cause? What's driving this cancer? What's plan B? If treatment isn't responding, what are you gonna do? How are you gonna pivot? Are you testing to find that before we see it in an imaging and in a tumor marker? Can you spot that earlier? Is there anything we're missing here? These are the questions that are powerful because this helps you to understand who you're working with and the work that they're doing. Because in real precision medicine, these are the questions that separate healthcare from detail to standard. Now let's talk about the blind spot, the standard of care system, and some of the problems in it. And everybody knows these are large institutions trying to do the best they can. It's not conspiracies. I'm not attacking anybody. These are just blind spots because these organizations are so big and they all pretty much use the NCCN guidelines, which are not n-of-1. They're not custom built on the individual. They are averages, double-blind placebo clinical trial work. That's for the averages. So there's a lot of blind spots in there. And unless you get precision testing and a second opinion, you won't see those blind spots that can give you a huge advantage. So these are some of the major issues. Standard oncology is to manage large populations with reproducible protocols. And I understand why they're dealing with large numbers, but averages are dangerous in cancer because two people with the same types of cancer can have totally different markers. It's very common, by the way. And when you do deep testing, you can see that. And nobody's really an average. All the cancer markers and these details can play a role in the treatment. It's not population health, it's you health. It's focused on your blueprint. Yeah. And that's the blind spot of standard oncology. We also see the same problem in often integrative care where it's one size fits all, natural vitamins, IVs, but it needs to be targeted based on the markers. Instead of a few markers like 24 in the basic standard oncology, we want 1,000+ markers. That makes all the difference. That's where we've emphasized our work at Invita Medical Centers for the last 2 and a half decades to go into these many, many markers and mapping and then custom building the medication. So we know the DNA next generation sequencing, the RNA the transcriptomics, the immune profiling, the immune spatial biology, the tumor microenvironment analysis. And now you're not just getting a name for the tumor or the disease, you're getting to understand what makes it work. In fact, you're getting a playbook, and that's very different. And I want you to ask those questions, even if you're not in our facilities, ask those questions to your oncologist. Anywhere you are, you should be asking those questions because they matter. They impact outcome. They impact matching you with the right treatment plan. It impacts you taking the right doses of the medicines because deeper testing provides better responses. We've we've seen this in the I-PREDICT and the WINTHR studies and in our own published paper in 2024, is that people respond better when they have targets. The immune system is engaged, the tumor microenvironment is analyzed, and that's where the future of oncology is. That makes all the difference, and we can remove a blind spot. The body's often treated like it's separate from the cancer. This is a huge error. Cancer does not live in a vacuum. It lives in the host, in the terrain, in the metabolism, inflammation, immune signaling. It lives in the patient who may be depleted of enzymes, nutrients, pathways of detoxification they need support in, right? Immune modulatory factors. These are important. The patient may have this inflammation, insulin resistance, toxins, disruptive gut microbiome, damaged sleep. And these aren't things standard oncology looks at. Putting you into a chemotherapy that may be for the average population, but not for you as a regimen. That's important to get here. And all too often this treats the body like background noise when in fact the body is the key to healing. After our team has been in this space for 2.5 decades, I can tell you that the body is the one that brings you to the healing. Even when you're doing chemo, even when you're doing targeted immunotherapy, even when you're doing these therapies, you're stimulating the body to do the healing. And so you want to answer these questions. Why is this treatment the right one for me? And right now, not just because this is what I have access to or what my insurance company's covering, but why is this right for me? Is it the right target? Is it in the right sequence? Is it building my immune system? Is the timing and the combinations correct? Or is it just vague? This is what we do. This is standard of care because that's the information you need answers to. Good cancer treatment in my experience, knowledge is explained in the detail of understanding the cancer patient's unique biology and their changes. We call that deep multiomics, and that technology continues to expand just in our laboratories today. And we have our own laboratories that do RNA, DNA, immunospatial biology. The technology is just amazing and expanding, but most patients around the world don't have access to that because it's considered research. It should be standard of care because more data guides, more data tells us clearly what the better options are. So if you're not getting this, you need to understand this better. And that's the key. You don't want to be treating cancer in the dark. We're in the future of oncology, 2026 beyond, going in the future. It's going to move more and more to N of 1, more and more targeting, more and more transcriptomics, understanding the cancer, the immune background. And you should know that because you actually have access to that today. That microenvironment, those targets, they make a difference. You should understand the actual vulnerabilities to your cancer because I've seen this, and as our doctors have over and over again, patients come in and they're on the wrong treatment. Then deeper testing reveals what the right targets are and they start to respond much better, better quality of life and better response rates. That's what we see with targeting. So good care should support the immune system, should be targeted for you, not one size fits all. It should have on, off-label integrative combinations that work to help you. This is the central key that I want to teach today in this podcast is that this targeting really does matter. The immune system is the first and last defense against cancer. I always use these terms. How do we make sure the treatment is cytotoxic, killing the cancer and not just cytostatic? Because today in modern oncology, a lot of it's slowing it down, buying time, but we actually wanna get rid of the cancer. We want the immune system activated and we want to get rid of the suppression so these cold tumors become hot and these cancers go into remission. That's the goal. That's what good multimodal cancer treatment looks like. Smart approaches, really outsmarting the cancer so it doesn't adapt. Yeah. You don't get rejection to treatment. People that get refractory, they're not responding and it's mutating too quick. And these, a lot of these dirty cancers move really quickly because the one-size-fits-all model isn't targeting the right targets for them. So over the years I've seen this, we've seen this as our group, and the best cancer care is not just one tool, it's the correct coordinated combinations, the correct targets at the right dose, not too much. You want to release the right immune system releases, the right immune support, the right metabolic support, and the right treatments that are in combination, nutrition, enzymes, you know, vitamins, the things you need to help heal, repair, polyphenols, nutrients. There's all these combinations that can be brought in from the integrative side, but you also need the right on/off-label chemotherapeutics that can be microdosed. Sometimes you have to get it directly to the tumor because giving it IV, it'll get lost and has to be directly delivered to the tumor. And you can do that with a catheter the size of a hair and directly come out because you're targeting it. You don't play chess with one move. You play it with a full board. That's how we think about cancer. And if your care team only thinks of it in one lane, you should at least ask whether a broader strategy exists and understand what those options are. Now let me shift into the things that do not usually make the brochure, the things patients and caregivers feel, but the system rarely says out loud. The caregiver is part of the treatment plan. This is one of the most important human lessons I've seen over the years. They need prayer. It's a spouse, a daughter, a son, a parent, a friend, the person who asks the second question after the doctor leaves a room, the person that prays with the patient and supports them and encourages them. That person matters tremendously. When caregivers burn out, the patients suffer. When caregivers get confused, scared, unsupported, and exhausted, the whole care structure can weaken. So one thing I wish every family did really early on is take care of the caregiver with purpose, not as an afterthought, on purpose, because cancer is not just a medical event, it's a family system event where you need friends and community and support and— it's the system around the patient that you don't want to collapse. Outcomes often get worse. It's strange that way when they don't get the support they need. Another lesson that does not make the brochure is the mindset. Mindset's so important. Now, I want to be careful here. I'm not saying that people cause cancer through bad thinking or something they thought wrong. No, I'm not saying that. I'm saying that positive thinking makes a difference. It doesn't cure the cancer, but it changes your attitude. And people with better attitude to respond better to treatment. That's really that simple. And getting your mindset in the mindset of healing, in the mindset of recovery, in the mindset of being open to letting your body heal, that's just so important. Engagement matters. It helps you fight cancer better. It gives your body and your immune system actually the ability to respond even better. So I've seen this over the years, people with a positive mental mindset that are encouraged. And the way I like to do this is reading the scriptures because you put in the word of God and it gives encouragement. It gives hope and healing. Having the right mindset alone obviously is not the only treatment plan, but it's an important part. Mindset does matter. It helps with compliance and the way you feel and recover. And just that also that ability to fight that comes up within you is important. Another thing patients need to hear early is financial reality has to be addressed sooner, not later. This is uncomfortable, but it's a real issue. Cancer affects families medically, emotionally, spiritually, and yes, financially. And when the financial conversation is delayed, the stress often becomes overwhelming at that exact moment the family needs the most clarity. So one practical lesson I would give families is this: have the financial conversation early. What's covered? What's not? What do you need to prepare for? Where are the pressure points? What choices may come up later? That's not negativity, that's preparation. Now I wanna slow down and give you a single lesson that I think everybody who has cancer or has a cancer diagnosis should hear. Not 10 lessons, one, just One. Here it is. Do not wait until you're out of options to start looking for real precision targeting. If you were my family member, I'd want depth early. I'd want 1,000 markers, not just 24. Not desperation late. I'd want to know early on if the treatment is working with adaptive monitoring and deeper testing. I'd want all my strategies up front and I'd want precision personalized care right at the center so I understand how everything's working. I'd want someone to look at the immune system. Yeah. I'd want them to see what's evading the immune system and how to get it to respond better. I'd want somebody to ask the questions about helping my body heal, my terrain respond, building a strategy around the biology of the body to heal. Because over 26 years, what we've seen as a team is the earlier patients are strengthened, have their options, understand the information, they always will respond better to care over and over again. And I've also seen what happens to people who are told there's nothing left and they walk away and they don't get answers and they don't get deeper testing. Oftentimes a disease progresses and things worsen. So we wanna make the body stronger and we want to have the right information before we do care. We don't want a narrow window. We want all these options available to us. That's why this is what is so important that we stay away from this phrase. There is nothing more that can be done. That can happen, but unless you've done precision testing and you've asked these deeper questions, you can't really say that because you're might be missing something. You don't understand what's driving the cancer. You may not have all the possible information in front of you to guide you. You don't have all the right data and you don't have all the right targeting. So what does this tumor actually respond to? What's the best strategy? What's the best immunotherapy? What's the best targets? Those are the questions that change the entire direction of care. And if there's one thing I hope you take from this podcast is this: cancer care should not begin with surrender to a category. It should begin with curiosity about the biology and activating your body's ability to heal itself. This is the difference between protocol mindset and the precision mindset. mindset. One treats the averages, the other looks at you and your blueprint. And if you found these lessons valuable and helpful, and I hope you did, and you want the simplest practical thing that you can actually start with this week, click this video right here. I'll walk you through 5 boring foods with real research behind them that help you support the body in both the pre— prevention and treatment of cancer that can help guide you, and you can start using them right away. I hope you found this helpful, and may the Lord bless you on your journey to healing.
